Product Information
GLIMEPIRIDE 2 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0373 per EA under NDC 16571077401. Its NADAC has been published 221 times since Jun 1, 2022.
FDA first approved this application on Jun 29, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571077401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202759FDA Approved
6/29/2012
TE Code
AB
On Market Since
6/29/2012
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 2 MG TABLET has been published 221 times since Jun 1, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0373 per EA |
|---|---|
| All-time high | $0.0408 (Jul 12, 2023) |
| All-time low | $0.0284 (Apr 17, 2024) |
| 52-week high | $0.0374 |
| 52-week low | $0.0295 |
| Median price | $0.0353 |
| Average price | $0.0348 |
| Largest weekly change | -26.3% (Apr 17, 2024) |
| Weeks tracked | 221 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 2 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0373 per EA (NDC 16571077401), effective Aug 19, 2026.
How has the price of GLIMEPIRIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 2 MG TABLET has held within roughly two percent of its current level. It has been tracked across 221 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 2 MG TABLET?
Since Jun 1, 2022, the NADAC for GLIMEPIRIDE 2 MG TABLET has ranged from a low of $0.0284 (Apr 17, 2024) to a high of $0.0408 (Jul 12, 2023), with a median of $0.0353 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 2 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIMEPIRIDE 2 MG TABLET, is $0.0358 per EA — about 4% below GLIMEPIRIDE 2 MG TABLET.
Who manufactures GLIMEPIRIDE 2 MG TABLET?
GLIMEPIRIDE 2 MG TABLET (NDC 16571077401) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.